jiayi-li23/proxann_data huggingface dataset:
Bill 113-S-2935 — Health / Drug and Alcohol Abuse
Subject: Health

Sober Truth on Preventing Underage Drinking Reauthorization Act or STOP Act - Amends the Public Health Service Act to reauthorize the program to reduce underage drinking for FY2015-FY2018.

Revises reporting requirements for state programs on underage drinking.

 Specifies additional requirements for the development of the national media campaign to prevent underage drinking.

Directs the Administrator of the Substance Abuse and Mental Health Services Administration to make grants to professional pediatric provider organizations to increase effective practices, including the screening of children and adolescents for alcohol use, to reduce the prevalence of alcohol use among individuals under the age of 21, including college students.

Directs the Secretary of Health and Human Services (HHS) to collect data and conduct or support new research on underage drinking that improves and conducts public health surveillance of alcohol use and alcohol-related conditions in states among individuals between age 18 and 20 by increasing the use of surveys, such as the Behavioral Risk Factor Surveillance System, to monitor binge and excessive drinking and related harms.

Amends the Federal Alcohol Administration Act to prohibit the manufacture, sale, distribution, or possession of powdered alcohol.
Bill 114-HR-667 — Health / Drug and Alcohol Abuse
Subject: Armed forces and national security

Veterans Equal Access Act

Directs the Secretary of Veterans Affairs (VA) to authorize VA health care providers to: (1) provide veterans with recommendations and opinions regarding participation in their state's marijuana programs, and (2) complete forms reflecting such recommendations and opinions.
Bill 114-HR-1717 — Health / Drug and Alcohol Abuse
Subject: Health

Sober Truth on Preventing Underage Drinking Reauthorization Act or the STOP Act

Amends the Public Health Service Act to reauthorize the program to reduce underage drinking for FY2016-FY2020.

Revises reporting requirements for state programs on underage drinking.

 Specifies additional requirements for the development of the national media campaign to prevent underage drinking.

Directs the Substance Abuse and Mental Health Services Administration to make grants to professional pediatric provider organizations to increase effective practices, including the screening of children and adolescents for alcohol use, to reduce the prevalence of alcohol use among individuals under the age of 21, including college students.

Directs the Department of Health and Human Services to collect data and conduct or support new research on underage drinking that carries out and improves public health surveillance of alcohol use and alcohol-related conditions in states among individuals between age 18 and 20 by increasing the use of surveys, such as the Behavioral Risk Factor Surveillance System, to monitor binge and excessive drinking and related harms.
Bill 114-HR-1725 — Health / Drug and Alcohol Abuse
Subject: Health

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

(Sec. 2) Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of state-administered controlled substance monitoring systems ensuring access to prescription history information for the investigative purposes of appropriate law enforcement, regulatory, and state professional licensing authorities.

 (Sec. 3) Amends the Public Health Service Act to revise and reauthorize through FY2020 the controlled substance monitoring program, including to:

 allow grants to be used to maintain and operate existing state controlled substance monitoring programs, require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees, require a state to provide HHS with aggregate data and other information to enable HHS to evaluate the success of the state's program, and expand the program to include any commonwealth or territory of the United States. Allows the Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes to make that information available to other entities for research purposes.

Requires a state receiving a grant to: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system both to them and society.
Bill 114-HR-1821 — Health / Drug and Alcohol Abuse
Subject: Health

Opioid Overdose Reduction Act of 2015

This bill exempts individuals from liability for harm caused by the emergency administration of an opioid overdose drug under certain circumstances. (An opioid is a drug with effects similar to opium, such as heroin.) The individuals exempted from liability are:

 a health care professional who prescribes or provides an opioid overdose drug to an individual at risk of experiencing an opioid overdose or to another individual in a position to assist the individual, if the individual has been educated about opioid overdose prevention and treatment by the health care professional or as part of a government opioid overdose program; an individual who provides an opioid overdose drug for emergency administration to another individual authorized to receive it as part of an opioid overdose program; and an individual who administers an opioid overdose drug to another individual who appears to have suffered an opioid overdose if the individual obtained the drug from a health care professional or as part of an opioid overdose program and was educated by the professional or program in the proper administration of the drug. These exemptions are inapplicable if the harm was caused by gross negligence or reckless misconduct.

States can preempt these exemptions by providing additional protections from liability for individuals that administer opioid overdose drugs, or by enacting legislation making the Act not applicable to state civil action involving only citizens from that state.
Bill 114-HR-1988 — Health / Drug and Alcohol Abuse
Subject: Health

Breaking Addiction Act of 2015

This bill directs the Secretary of Health and Human Services to provide for waiver of the limitation on medical assistance to certain patients in an institution for mental diseases (IMD limitation) in order to permit medical assistance under title XIX (Medicaid) of the Social Security Act for the treatment of a substance use condition for a qualified individual in a community-based institution for mental diseases.
Bill 114-HR-2298 — Health / Drug and Alcohol Abuse
Subject: Health

Medicare Patient Safety and Drug Abuse Prevention Act 

Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to authorize a prescription drug plan (PDP) sponsor to establish a drug management program for at-risk beneficiaries.

Requires a PDP sponsor, with respect to covered part D drugs, to have in place, directly or through appropriate arrangements, a utilization management tool designed to prevent: (1) the abuse of frequently abused drugs by individuals, and (2) the diversion of such drugs at pharmacies.

Directs the Department of Health and Human Services (HHS) to authorize Medicare drug integrity contractors (MEDICs) to accept directly an individual's prescription and necessary medical records from pharmacies, PDPs, and physicians in order for MEDICs to provide information relevant to determining whether the individual is an at-risk beneficiary.

Requires the Inspector General of HHS to study the effectiveness of MEDICs in identifying, combating, and preventing fraud under the Medicare program.

Expresses the sense of Congress that Medicare Advantage organizations and PDP sponsors should consider using e-prescribing and other health information technology tools to support combating fraud under MA-PD plans and prescription drug plans under parts C (Medicare+Choice) and D.
Bill 114-HR-2463 — Health / Drug and Alcohol Abuse
Subject: Crime and law enforcement

Dispose Responsibly of your Pills Act of 2015 or the DROP Act of 2015

Authorizes the Attorney General, in coordination with the Administrator of the Drug Enforcement Administration (DEA), the Secretary of Health and Human Services, and the Director of the Office of National Drug Control Policy, to make grants to eligible entities to expand or make available disposal sites for unwanted prescription medications.

Defines "eligible entity" to include:

 a state, local, or tribal law enforcement agency; a manufacturer, distributor, or reverse distributor of prescription medications; a retail pharmacy; a registered narcotic treatment program; a hospital or clinic with an on-site pharmacy; and an eligible long-term care facility. Requires a recipient to use a grant for:

 expenses of a prescription drug disposal site; implementing disposal procedures and processes and community education strategies; replicating a prescription drug take back initiative throughout multiple jurisdictions; and training of law enforcement officers and other community participants. Limits grants to not more than $250,000 for not longer than two years.

Directs the Attorney General to make a grant: (1) to provide technical assistance and training for a grant recipient, and (2) for evaluation of each recipient's performance. Requires recipients to report each fiscal year on: (1) the effectiveness of their prescription drug take back programs, and (2) the effect of disposal efforts on drug circulation.
Bill 114-HR-2805 — Health / Drug and Alcohol Abuse
Subject: Health

Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015

This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veterans Affairs, the Department of Defense, and the Drug Enforcement Administration (DEA), to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practices for pain management and prescription of pain medication.

This bill amends the Public Health Service Act to revise and extend through FY2020 the controlled substance monitoring program.

Government entities receiving nonidentifiable information from a controlled substance monitoring database for research purposes may make that information available to other entities for research purposes.

A state receiving a grant for a controlled substance monitoring program must: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system. This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to extend the Edward Byrne Memorial Justice Assistance Grant Program through FY2020.

HHS must advance education and awareness of the risk of abuse of prescription opioids (drugs with effects similar to opium).

The Office of National Drug Control Policy (ONDCP), in coordination with HHS and the DEA, must establish a national drug awareness campaign that emphasizes the similarities between heroin and prescription opioids.

The DEA, in coordination with HHS and ONDCP, may make grants to state, local, or tribal governments to create demonstration programs to allow first responders to prevent opioid overdose death by administering an opioid overdose reversal drug (e.g., naloxone).
Bill 114-HR-2850 — Health / Drug and Alcohol Abuse
Subject: Health

Stop Overdose Stat Act of 2015

This bill amends the Public Health Service Act to require the Substance Abuse and Mental Health Services Administration (SAMHSA) to enter into cooperative agreements to reduce deaths from drug overdoses by: (1) purchasing and distributing naloxone (a medication that rapidly reverses overdose from heroin or other drugs with effects similar to opium) or a similar drug; and (2) educating or training the public, first responders, or health professionals on drug overdose prevention or response.

SAMHSA must establish a coordinating center and develop a plan to reduce drug overdose deaths by educating the public about overdose prevention and recommending improvements to overdose prevention programs.

The Centers for Disease Control and Prevention must improve drug overdose surveillance by entering into cooperative agreements to: (1) provide training to improve identification of drug overdose as the cause of death, and (2) establish a national program for reporting drug overdoses.

The National Institute on Drug Abuse (NIDA) must prioritize, conduct, and support research on circumstances that contribute to drug overdose, drugs associated with fatal overdose, and overdose prevention methods. NIDA must support research on drug overdose treatments that can be administered by lay persons or first responders.
Bill 114-HR-3250 — Health / Drug and Alcohol Abuse
Subject: Health

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

DXM Abuse Prevention Act of 2015

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of a drug containing dextromethorphan (DXM, a cough suppressant and drug of abuse) to an individual under age 18 unless the individual has a prescription or is actively enrolled in the military. Retailers selling DXM must implement a verification system to ensure compliance. Civil monetary penalties that escalate upon repeated violation are imposed.

(Sec. 3) Unfinished DXM may only be possessed by, distributed to, and received by persons registered with the Food and Drug Administration as producers of a drug or medical device or otherwise allowed to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients. Common carriers distributing unfinished DXM between authorized persons are exempted. Civil monetary penalties are imposed for possession and distribution violations.
Bill 114-HR-3676 — Health / Drug and Alcohol Abuse
Subject: Health

Expanding Opportunities for Recovery Act of 2015

This bill requires the Center for Substance Abuse Treatment in the Substance Abuse and Mental Health Services Administration to award grants to states to expand access to clinically appropriate services for opioid abuse or addiction. States must use these grants to provide up to 60 consecutive days of services to individuals who otherwise would not have access to substance abuse services.
Bill 114-HR-3677 — Health / Drug and Alcohol Abuse
Subject: Health

Opioid Abuse Prevention and Treatment Act of 2015

This bill requires the Department of Health and Human Services (HHS) to award grants to states to develop a peer review process to identify and investigate questionable or inappropriate prescribing and dispensing patterns of drugs classified as schedule II or III under the Controlled Substances Act, which are drugs with an accepted medical use that have the potential to be abused and addictive.

This bill amends the Public Health Service Act to require HHS to establish grant programs to: (1) facilitate training to increase the capacity of health care providers to screen and treat patients to prevent drug abuse, and (2) develop continuing education criteria that allow health profession boards or state agencies to certify appropriate education for safe prescribing of schedule II or III drugs. The Health Resources and Services Administration must award grants to evaluate the prospect of state health professions boards expanding the authority of providers to prescribe drugs to treat drug abuse.

The Drug Enforcement Administration must request that practitioners registered to dispense controlled substances screen patients for potential drug abuse before prescribing a schedule II or III drug.

The Food and Drug Administration must consider whether naloxone (a prescription drug used to rapidly reverse an overdose of heroin or other opioids, which are drugs with effects similar to opium) should be available without a prescription.

HHS must convene or coordinate with an interagency working group to encourage states and local governments to increase opportunities for disposal of opiates (drugs derived from opium) and to reduce opportunities for abuse of opiates.

The Government Accountability Office must review federal opioid abuse activities and make recommendations to reduce opioid abuse and overdoses.
Bill 114-HR-3680 — Health / Drug and Alcohol Abuse
Subject: Health

Co-Prescribing to Reduce Overdoses Act of 2016

(Sec. 2) This bill permits the Department of Health and Human Services (HHS) to establish a grant program to support prescribing opioid overdose reversal drugs, such as naloxone, for patients at an elevated risk of overdose, including patients prescribed an opioid. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)

Grant recipients may use the funds to purchase opioid overdose reversal drugs, establish a program for prescribing such drugs, train health care providers and pharmacists, track patients and outcomes, offset patient cost sharing, conduct community outreach, and connect patients to treatment.

(Sec. 3) HHS may provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing opioid overdose reversal drugs for patients at an elevated risk of overdose.

(Sec. 4) This bill amends the Public Health Service Act to reduce, as an offset, the authorization of appropriations for Centers for Disease Control and Prevention facilities for FY2018.
Bill 114-HR-3889 — Health / Drug and Alcohol Abuse
Subject: Crime and law enforcement

Safer Prescribing of Controlled Substances Act

This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration, as a condition of granting or renewing the registration of a covered practitioner to dispense, or conduct research with, controlled substances in schedule II, III, IV, or V, to require such practitioner to complete training that the Department of Health and Human Services (HHS) determines meets the requirements of this bill. It defines a "covered practitioner" as a practitioner that is not a hospital, pharmacy, or veterinarian.

It requires such training to expose covered practitioners to:

 best practices for pain management, including alternatives to prescribing controlled substances; responsible prescribing of pain medications; methods for diagnosing, treating, and managing a substance use disorder, including evidence-based nonpharmacological therapies; ways of linking patients to evidence-based treatment for substance use disorders; and tools to manage adherence and diversion of controlled substances. The Substance Abuse and Mental Health Services Administration must establish or support the establishment of at least one free, online training module that meets such requirements to be provided to any covered practitioner registered or applying for registration.

The bill requires HHS: (1) to establish, maintain, and periodically update a publicly available database providing information on such training modules; and (2) within five years after enactment of this bill, to evaluate and make publicly available a report describing how exposure to training required by this bill has changed prescribing patterns of controlled substances.
Bill 114-HR-4076 — Health / Drug and Alcohol Abuse
Subject: Health

The Reforming and Expanding Access to Treatment Act or the TREAT Act

This bill amends title XIX (Medicaid) of the Social Security Act to allow federal payment for qualified substance use disorder services furnished to inmates in public institutions under state Medicaid programs. "Qualified substance use disorder services" include medication or behavioral treatment administered to eliminate, mitigate, treat, or cure an individual's substance abuse disorder or use or abuse of drugs.

The Substance Abuse and Mental Health Services Administration shall not establish, maintain, or implement any policy that restricts its statutorily authorized provision or support of substance abuse treatment for incarcerated individuals.
Bill 114-HR-4229 — Health / Drug and Alcohol Abuse
Subject: Crime and law enforcement

Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015

This bill amends the Controlled Substances Act to include in the definition of a "controlled substance analogue" a substance designated as such by the Controlled Substance Analogue Committee (established by this bill).

It directs the Drug Enforcement Administration (DEA) to establish such Committee as an interagency committee headed by the DEA and comprised of scientific experts in the fields of chemistry and pharmacology from the DEA, the National Institute on Drug Abuse, the Centers for Disease Control and Prevention, and any other federal agency determined by the DEA to be appropriate.

 The Committee may designate, and shall establish and maintain a list of, controlled substance analogues determined to be similar to a schedule I or II controlled substance in either chemical structure or predictive effect on the body in such a manner as to make it likely that the substance will, or can be reasonably expected to, have a potential for abuse. The DEA must publish a description of each designation made by the Committee.

The bill amends the Controlled Substances Import and Export Act to prohibit the importation of any controlled substance analogue except pursuant to such notification or declaration as the DEA may prescribe.

It directs the U.S. Sentencing Commission to review and, if appropriate, amend the federal sentencing guidelines and policy statements to ensure that they provide adequate penalties for any offense involving the unlawful manufacturing, importing, exporting, or trafficking of controlled substance analogues and similar offenses.
Bill 114-HR-4279 — Health / Drug and Alcohol Abuse
Subject: Armed forces and national security

This bill requires the Department of Veterans Affairs (which currently is simply authorized) to disclose information about a veteran or dependent to a state controlled substance monitoring program to the extent necessary to prevent misuse and diversion of prescription medicines.
Bill 114-HR-4378 — Health / Drug and Alcohol Abuse
Subject: Health

Access to Substance Abuse Treatment Act of 2016

This bill amends the Public Health Service Act to allow the Substance Abuse and Mental Health Services Administration (SAMHSA) to make grants to: (1) increase the availability of treatment for abuse of opioids (drugs with effects similar to opium, such as heroin), cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and phencyclidine (PCP); (2) provide vouchers to individuals in underserved populations for services related to such treatment; and (3) establish programs to provide for and coordinate the provision of services, including medical services, job training services, and housing assistance, to individuals reentering the community after successfully receiving treatment for abuse of such substances.

The grant program to provide residential substance abuse treatment to pregnant and postpartum women is revised to: (1) make caregiver parents eligible for treatment, (2) make Indian tribes and tribal organizations eligible for grants, and (3) set forth the priority for allocation of grants.

The National Institute on Drug Abuse must conduct research on the effectiveness of drugs to reduce the problems associated with stimulant abuse.

The Department of Health and Human Services must seek to enter into a contract with the National Academy of Medicine (formerly known as the Institute of Medicine) to complete a literature review on the effectiveness of drugs for the treatment of stimulant abuse.

The Government Accountability Office must study: (1) the impact of the programs authorized by this Act, (2) how the level of federal funding available for such treatment compares to the amount necessary to provide adequate treatment, and (3) the cost savings of effective treatment due to the reduced need for criminal justice and other services.